check_circleStudy Completed

Pneumonia

Community-Acquired Pneumonia (CAP) surveillance

Trial purpose

Prospective, non-interventional, multi-center study. 7 investigative centers will involved in China. Around 560 CAP outpatients or inpatients will be screened until 56 M. pneumoniae isolates collected.

Key Participants Requirements

Sex

Both

Age

18 - N/A
  • - Chinese adult (male or female) ≥18 years old
    - Outpatients or inpatients who suffer from CAP

  • -

Trial summary

Enrollment Goal
560
Trial Dates
September 2010 - January 2013
Phase
N/A
Could I Receive a placebo
No
Products
No Drug
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many Locations, China

Primary Outcome

  • In vitro Minimal Inhibitory Concentration Detection
    date_rangeTime Frame:
    Up to 27 months
    enhanced_encryption
    Safety Issue:
    No

Secondary Outcome

  • In vitro Gene Mutation Detection
    date_rangeTime Frame:
    Up to 15 months
    enhanced_encryption
    Safety Issue:
    No

Trial design

Community-Acquired Pneumonia (CAP) Mycoplasma Surveillance
Trial Type
Observational
Intervention Type
Other
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A